Skip to main content
FinSpry Logo
FinSpry
SYRE logo
SYRE
(NASDAQ)
Spyre Therapeutics, Inc.
$71.92-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Spyre Therapeutics (SYRE) Stock Price & Financial Analysis

Spyre Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$67.88 - $72.47
52-Week High$78.80
52-Week Low$13.93
Open$68.64
Volume1.06M
Average Volume (3M)1.42M
Market Cap23.05B
Shares Outstanding346.05M
Price to Sales (P/S)254.75
Price to Book (P/B)32.23
EV/EBITDA-106.87
Revenue (TTM)90.49M
Net Income (TTM)-155.20M
Free Cash Flow (TTM)-169.25M
EPS (TTM)$-1.15
Profit Margin-171.51%
Operating Margin-231.58%
Return on Equity (ROE)-21.70%
Debt to Equity0.00
50-Day MA$56.37
200-Day MA$33.19
52-Week Change411.92%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Spyre Therapeutics

What is the current stock price for SYRE?

As of the latest trading session, SYRE stock trades at $71.92. The 52-week range is $13.93–$78.80, with a day range of $67.88–$72.47.

What is the P/E ratio for SYRE?

The P/E ratio (Price-to-Earnings) for SYRE is shown in the Key Statistics section. This valuation metric helps compare Spyre Therapeutics, Inc. to industry peers.

Does SYRE pay dividends?

Spyre Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for SYRE?

Based on 10 analysts, the consensus for SYRE is Strong Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of SYRE?

Spyre Therapeutics's market capitalization is $24.89B, classifying it as a large-cap company. Spyre Therapeutics operates in the Healthcare sector within the Biotechnology industry.